Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prulifloxacin in acute bacterial rhinosinusitis
2011-002955-33Phase 4Completed
- Sponsor
- Angelini Pharma
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of prulifloxacin in Acute bacterial rhinosinusitis (ABRS), sponsored by Angelini Pharma. Primary endpoint: Clinical efficacy at test-of-cure. Started Dec 2014; status: completed.
02
Drugs
prulifloxacin
03
Conditions
Acute bacterial rhinosinusitis (ABRS)
Beyond the preview
Go deeper on 2011-002955-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002955-33.